OCUL Smart Money
Ocular Therapeutix, Inc.
1W: +1.1%
1M: -12.3%
3M: -19.6%
YTD: -43.1%
1Y: -41.5%
3Y: +186.0%
5Y: -41.5%
$6.72
+0.25 (+3.86%)
Pre-Market: $7.16 (+0.44, +6.55%)
Weekly Expected Move ±13.0%
$5
$6
$6
$7
$8
Credit Risk of going bust: higher than 54% of companies Debt: 5.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.05 (down 99.2%), Ocular Therapeutix, Inc. would be worth roughly what it owes.
Total debt $79.4M against a stock market value of $1.48B.
Distance to default 4.76 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $39.5M (short-term plus half of long-term), stock volatility 73.9%; Altman Z'' 0.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.05 (down 99.2%), Ocular Therapeutix, Inc. would be worth roughly what it owes.
Total debt $79.4M against a stock market value of $1.48B.
Distance to default 4.76 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $39.5M (short-term plus half of long-term), stock volatility 73.9%; Altman Z'' 0.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026304
Institutions Holding
-17 vs prior
132.0%
Ownership
+15.62%
35
New
103
Increased
118
Reduced
38
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Anderman Todd | officer: chief legal officer | S-Sale | 11,984 | $7.29 | $87K | Filing |
| 2026-10-02 | Heier Jeffrey S. | officer: chief scientific officer | S-Sale | 10,869 | $7.05 | $77K | Filing |
| 2026-10-02 | Kaiser Peter | officer: chief development officer | S-Sale | 9,990 | $7.05 | $70K | Filing |
| 2026-08-31 | Notman Donald | officer: chief operating officer | S-Sale | 1,099 | $10.24 | $11K | Filing |
| 2026-08-25 | Dugel Pravin | officer: see remarks | G-Gift | 50,092 | $— | $0 | Filing |
| 2026-08-24 | Heier Jeffrey S. | officer: chief scientific officer | S-Sale | 3,296 | $10.78 | $36K | Filing |
| 2026-08-24 | Kaiser Peter | officer: chief development officer | S-Sale | 3,035 | $10.77 | $33K | Filing |
| 2026-08-24 | Nayak Sanjay | officer: chief strategy officer | S-Sale | 1,897 | $10.78 | $20K | Filing |
| 2026-08-24 | Dugel Pravin | officer: see remarks | S-Sale | 21,649 | $10.77 | $233K | Filing |
| 2026-06-16 | Dugel Pravin | officer: see remarks | G-Gift | 50,092 | $— | $0 | Filing |
| 2026-06-10 | Hong Seung Suh | director | A-Grant/Award | 14,000 | $— | $0 | Filing |
| 2026-06-10 | LINDSTROM RICHARD L MD | director | A-Grant/Award | 14,000 | $— | $0 | Filing |
| 2026-06-10 | RAINES MERILEE | director | A-Grant/Award | 14,000 | $— | $0 | Filing |
| 2026-06-10 | Williams Leslie J. | director | A-Grant/Award | 14,000 | $— | $0 | Filing |
| 2026-06-10 | Robins Jason Shand | officer: chief financial officer | A-Grant/Award | 15,441 | $— | $0 | Filing |
| 2026-06-10 | Graves Adrienne L | director | A-Grant/Award | 14,000 | $— | $0 | Filing |
| 2026-06-10 | Warden Charles M | director | A-Grant/Award | 14,000 | $— | $0 | Filing |
| 2026-06-03 | Waheed Nadia | officer: chief medical officer | S-Sale | 14,828 | $8.27 | $123K | Filing |
| 2026-05-28 | Dugel Pravin | officer: see remarks | G-Gift | 394,696 | $— | $0 | Filing |
| 2026-05-26 | Nayak Sanjay | officer: chief strategy officer | S-Sale | 1,858 | $8.20 | $15K | Filing |
| 2026-05-26 | Heier Jeffrey S. | officer: chief scientific officer | S-Sale | 3,018 | $8.20 | $25K | Filing |
| 2026-05-26 | Kaiser Peter | officer: chief development officer | S-Sale | 2,967 | $8.20 | $24K | Filing |
| 2026-05-26 | Dugel Pravin | officer: see remarks | S-Sale | 21,156 | $8.20 | $173K | Filing |
| 2026-04-09 | Dugel Pravin | officer: see remarks | G-Gift | 394,696 | $— | $0 | Filing |
| 2026-02-23 | Heier Jeffrey S. | officer: chief scientific officer | S-Sale | 3,057 | $8.28 | $25K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 32,844,043 | $323M | +190,279 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 19,686,282 | $193M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 19,376,555 | $190M | +3,243,624 | 2026-06-30 | Filing |
| Avoro Capital Advisors LLC | 12,540,000 | $123M | +225,000 | 2026-06-30 | Filing |
| Summer Road LLC | 12,208,296 | $120M | +328,471 | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 10,346,926 | $102M | — | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 8,832,595 | $87M | +113,556 | 2026-06-30 | Filing |
| Logos Global Management LP | 5,300,000 | $52M | +1,450,000 | 2026-06-30 | Filing |
| STATE STREET CORP | 5,233,282 | $51M | +524,863 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 5,021,092 | $49M | +491,907 | 2026-06-30 | Filing |
| Point72 Asset Management, L.P. | 3,292,193 | $32M | -2,242,792 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 2,783,367 | $27M | +2,133,611 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 2,270,707 | $22M | -421,915 | 2026-06-30 | Filing |
| Octagon Capital Advisors LP | 2,075,000 | $20M | -1,091,600 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,973,130 | $19M | +378,464 | 2026-06-30 | Filing |
| NORTHERN TRUST CORP | 1,799,426 | $18M | +273,800 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,761,754 | $17M | +651,388 | 2026-06-30 | Filing |
| Nuveen, LLC | 1,697,274 | $17M | +1,286,194 | 2026-06-30 | Filing |
| Woodline Partners LP | 1,667,609 | $16M | — | 2026-06-30 | Filing |
| TCG Crossover Management, LLC | 1,647,752 | $16M | — | 2026-06-30 | Filing |